Best Pharmaceutical Consulting Company

 

INTRODUCTION

Pangraf 1 capsules are used with other medicines to prevent your body from rejecting new organs (for example, liver, kidney or heart) after transplantation. The drug belongs to a class of drugs called immunosuppressants. It works by weakening the body's immune system, so it does not attack new organs.

The amount and frequency of taking Pangraf 1 capsules depends on the type of transplant, weight, and other medications you are taking. Please follow the doctor's instructions carefully. You should take it on an empty stomach at least 1 hour before meals or 2 hours after meals. Even if you feel good, take this medication regularly to get the most benefit and continue taking it. If you stop taking it, you may increase your chances of rejecting organ transplants.

Pangraf 1 capsule has many potential side effects. It can cause or exacerbate diabetes and kidney and liver problems. These require urgent medical care. Other common side effects include nausea, stomach pain, diarrhea and trouble sleeping. If these or other side effects do not disappear or get worse, please tell your doctor. Since it lowers your immune system, you may also get more infections than usual.

Before taking this medication, tell your doctor if you have kidney, liver or heart problems, diabetes or high blood pressure. Also, let your doctor know that you are taking other medicines, especially for infections, pain and arthritis. These drugs and other drugs may affect or be affected by this drug. When taking it, exposure to sunlight and ultraviolet (ultraviolet rays) should be restricted, because immunosuppressants may increase the risk of skin cancer.

Both men and women should use effective contraceptives to prevent pregnancy. Unless clearly needed, it is generally not recommended to use the drug during pregnancy or breastfeeding. Before and during treatment, you will need frequent medical check-ups to monitor the progress of the condition, and you will need to check your blood pressure frequently.

pharma consulting company

USES OF PANGRAF CAPSULE

Prevention of organ rejection in transplant patient

BENEFITS OF PANGRAF CAPSULE

Pangraf 1 capsules belong to a group of drugs called immunosuppressants. When your immune system treats a new organ as an intruder and attacks it, organ rejection occurs. This medication weakens your immune response (usually fighting infection) and reduces the chance of your body attacking the transplanted organ. I use it in combination with other drugs to make your transplant surgery more likely to be successful. You should continue to take this medicine and do not stop taking it unless your doctor says so.

SIDE EFFECTS OF PANGRAF CAPSULE

Most side effects do not require any medical care and will disappear as the body adjusts to the medication. If they persist or you are worried about them, please consult your doctor
  • Diarrhea
  • Increased glucose level in blood
  • Increased thirst
  • Kidney damage
  • Liver damage
  • Nausea
  • Stomach pain
It is very challenging to find a good pharma consulting company which is rapidly growing with remarkable note, but there are some companies that provides numerous amount of pharmaceutical consulting services

Comments

Post a Comment

Popular posts from this blog

Best Pharma Consulting Company

Image
 Drug Name Atriance 5 mg/ml infusion solution 2. Qualitative and quantitative composition Each milliliter of solution contains 5 mg of Nelarabine. Each vial contains 250 mg of Nelarabine. Excipients with known effects Each milliliter of solution contains 1.770 mg (77 micromoles) of sodium. For a complete list of excipients, see section 6.1. 3. Drug form Infusion solution. Clear colorless solution. 4. Clinical details 4.1 Treatment indications Nelarabine is suitable for the treatment of patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) who have not responded or relapsed after treatment with at least two chemotherapy regimens. Because the number of patients in these conditions is small, the information supporting these indications is based on limited data. 4.2 Modes and methods of administration Nelarabine can only be administered under the guidance of a doctor who has experience in the use of cytotoxic agents. Ontology The complete b...
Read more

Best Pharma Consulting Company

Image
  What is Adcetris and how to use it? Adcetris is a prescription medicine used to treat symptoms. Adcetris can be used alone or together with other drugs. Adcetris belongs to a class of drugs, called anti-tumor drugs, anti-microtubules; anti-Nectin-4 monoclonal antibodies; anti-tumor drugs, anti-CD30 monoclonal antibodies. It is not clear whether Adcetris is safe and effective in children. What are the possible side effects of Adcetris? Adcetris can cause serious side effects, including: measles, Difficulty breathing, Swelling of your face, lips, tongue or throat, fever, sore throat, Burn in your eyes Skin pain The red or purple rash spreads and causes blistering and peeling, dizziness, nausea, Chills Itching, Difficulties in speech, thought, vision or muscle movement, numbness, weakness, Burning pain Numbness Loss of sensation in the arms or legs, Sudden chest pain or pressure, respite dry cough, Shortness of breath, Pain or burning when urinating, thirst, Increased urination, Dry...
Read more

Best Pharma Consulting Company

Image
  Indications Instruct VENCLEXTA: For the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Combine with azacitidine, decitabine or low-dose cytarabine for the treatment of newly diagnosed adult acute myeloid leukemia (AML): 75 years or older, or Patients with comorbidities cannot use intensive induction chemotherapy. Important safety information Contraindications In patients with CLL/SLL, simultaneous use of VENCLEXTA with strong CYP3A inhibitors is contraindicated because it may increase the risk of tumor lysis syndrome (TLS). Tumor lysis syndrome Patients treated with VENCLEXTA developed tumor lysis syndromes, including fatal events and renal failure requiring dialysis. VENCLEXTA can cause rapid tumor reduction, so in all CLL/SLL patients, there is a risk of TLS during the start and the start phase, and during the restart period after the dose is interrupted. Changes in blood chemistry consistent with TLS need to be dealt wi...
Read more